Company: CERO
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001213900-25-032134
Chunk: 877

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 9C
Chunk 877
---
 -  
     -  
     (85,500)
  
    Stock-based
    compensation 
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     924,668  
     -  
     -  
     924,668 

    Net
    loss 
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     (7,732,212) 
     (7,732,212)
  
    Balance
    at 12/31/2024 (Successor) 
     1,894  
    $1,708,396  
     273  
    $218,051  
     2,853  
    $1,249,999  
     2,415,883  
    $242  
    $67,142,046  
    $(1,295,444) 
    $(70,917,853) 
    $(1,894,563)

    Convertible
    Preferred Stock  

    Additional  
       
    Total 

    Series
    Seed  
    Series
    A  
    Common
    Stock  
    Paid-in  
    Accumulated  
    Stockholders’ 

    Shares  
    Amount  
    Shares  
    Amount  
    Shares  
    Amount  
    Capital  
    Deficit  
    Deficit 

    Balance
    at January 1, 2023 (Predecessor) 
     5,155,703  
     4,077,560  
     22,764,764  
     38,023,784  
     5,830  
     1  
     929,463  
     (35,800,244) 
     (34,870,780)
  
    Issuance
    of common stock from exercise of stock options 
     -  
     -  
     -  
     -  
     15  
           -  
     5